Viewing Study NCT00247650


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-03-31 @ 11:14 PM
Study NCT ID: NCT00247650
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2005-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neoadjuvant, postmenopausal women, breast cancer, hormonal therapy, bisphosphonate View